NCT01984580View on ClinicalTrials.gov

Effect of Zinc on Barrett's Metaplasia

PHASE1UnknownINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

March 31, 2015

Study Completion Date

December 31, 2015

Conditions
Barrett's Metaplasia
Interventions
DRUG

zinc gluconate

26.6 mg zinc BID (as zinc gluconate)

Trial Locations (1)

19096

RECRUITING

Lankenau Institute for Medical Research, Wynnewood

Sponsors

Lead Sponsor

Main Line Health
All Listed Sponsors
collaborator

Sharpe-Strumia Research Foundation

OTHER

lead

Main Line Health

OTHER

NCT01984580 - Effect of Zinc on Barrett's Metaplasia | Biotech Hunter | Biotech Hunter